Jazz Pharmaceuticals Director Norbert G. Riedel Disposes Shares for Tax Obligations

Executive Summary

On September 2, 2026, Jazz Pharmaceuticals plc ($JAZZ) director Norbert G. Riedel filed a Form 4 reporting dispositions of ordinary shares on August 31, 2026, totaling 1,706 shares valued at approximately $411,856.90.

Transaction Breakdown

• Security: Ordinary Shares
• Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
• Transaction Details:
  • Tranche 1: 14 shares disposed at $244.6443 per share ($3,425.02)
  • Tranche 2: 1,692 shares disposed at $241.3900 per share ($408,431.88)
  • Total Disposed: 1,706 shares for an aggregate value of $411,856.90
• Post-Transaction Holdings:
  • Direct Ownership: 6,923 ordinary shares
  • Indirect Ownership: 10,630 ordinary shares held via Trust

Strategic & Market Implications

• Purpose: According to the footnotes, these shares were withheld/sold solely to satisfy tax withholding obligations triggered by the vesting of previously granted restricted stock units (RSUs).
• Market Sentiment: Low informational value for open-market sentiment, as mandatory or automated tax-withholding dispositions do not reflect discretionary insider selling.